Conversion of Mild Cognitive Impairment to Alzheimer Disease in Monolingual and Bilingual Patients

被引:19
|
作者
Berkes, Matthias [1 ]
Bialystok, Ellen [1 ,2 ]
Craik, Fergus I. M. [2 ]
Troyer, Angela [3 ,4 ]
Freedman, Morris [2 ,5 ,6 ]
机构
[1] York Univ, Dept Psychol, 4700 Keele St, Toronto, ON M3J 1P3, Canada
[2] Baycrest, Rotman Res Inst, Toronto, ON, Canada
[3] Univ Toronto, Dept Psychol, Toronto, ON, Canada
[4] Baycrest, Neuropsychol & Cognit Hlth Program, Toronto, ON, Canada
[5] Mt Sinai Hosp, Dept Med, Div Neurol, Baycrest, Toronto, ON, Canada
[6] Univ Toronto, Toronto, ON, Canada
来源
ALZHEIMER DISEASE & ASSOCIATED DISORDERS | 2020年 / 34卷 / 03期
基金
加拿大自然科学与工程研究理事会; 美国国家卫生研究院;
关键词
Alzheimer disease; mild cognitive impairment; conversion; bilingualism; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; DEMENTIA; BRAIN; ONSET; AGE; EDUCATION; MULTILINGUALISM; RECOMMENDATIONS;
D O I
10.1097/WAD.0000000000000373
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: Conversion rates from mild cognitive impairment (MCI) to Alzheimer disease (AD) were examined considering bilingualism as a measure of cognitive reserve. Methods: Older adult bilingual (n=75) and monolingual (n=83) patients attending a memory clinic who were diagnosed with MCI were evaluated for conversion to AD. Age of MCI and AD diagnoses and time to convert were recorded and compared across language groups. Patients: Patients were consecutive patients diagnosed with MCI at a hospital memory clinic. Results: Bilingual patients were diagnosed with MCI at a later age than monolingual patients (77.8 and 75.5 y, respectively), a difference that was significant in some analyses. However, bilingual patients converted faster from MCI to AD than monolingual patients (1.8 and 2.8 y, respectively) resulting in no language group difference in age of AD diagnosis. This relationship held after accounting for education, cognitive level, immigration status, and sex. Discussion: The findings suggest that greater cognitive reserve as measured by language status leads to faster conversion between MCI and AD, all else being equal.
引用
收藏
页码:225 / 230
页数:6
相关论文
共 50 条
  • [31] Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
    Hansson, Oskar
    Zetterberg, Henrik
    Vanmechelen, Eugeen
    Vanderstichele, Hugo
    Andreasson, Ulf
    Londos, Elisabet
    Wallin, Anders
    Minthon, Lennart
    Blennow, Kaj
    NEUROBIOLOGY OF AGING, 2010, 31 (03) : 357 - 367
  • [32] Group cognitive therapy in patients with mild cognitive impairment and Alzheimer's disease
    Urrutia Amable, Nelky
    INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 2016, 108 : 126 - 126
  • [33] Alzheimer's Disease and mild cognitive impairment
    Kelley, Brendan J.
    Petersen, Ronald C.
    NEUROLOGIC CLINICS, 2007, 25 (03) : 577 - +
  • [34] Polymorphisms in the AACT gene and cognitive decline as a risk marker of conversion to Alzheimer's disease in patients with mild cognitive impairment
    Cabranes, JA
    Barabash, A
    Marcos, A
    Gil, P
    Fernández, C
    Encinas, M
    Domínguez, M
    Payno, M
    López-Ibor, JJ
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 114 (07): : 827 - 827
  • [35] Mild cognitive impairment: Is it Alzheimer's disease or not?
    Petersen, RC
    Bennett, D
    JOURNAL OF ALZHEIMERS DISEASE, 2005, 7 (03) : 241 - 245
  • [36] Mild cognitive impairment: Is it Alzheimer's disease?
    Peteren, R.
    CLINICAL NEUROPSYCHOLOGIST, 2007, 21 (04) : 687 - 687
  • [37] Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease
    Guidi, I
    Galimberti, D
    Lonati, S
    Novembrino, C
    Bamonti, F
    Tiriticco, M
    Fenoglio, C
    Venturelli, E
    Baron, P
    Bresolin, N
    Scarpini, E
    NEUROBIOLOGY OF AGING, 2006, 27 (02) : 262 - 269
  • [38] Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease
    Kesler, Anat
    Vakhapova, Veronika
    Korczyn, Amos D.
    Naftaliev, Elvira
    Neudorfer, Meira
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2011, 113 (07) : 523 - 526
  • [39] Brain metabolism in patients with mild cognitive impairment and Alzheimer's disease
    Samaranch, L
    Arbizu, J
    Martinez-Lage, P
    Lamet, I
    Masdeu, J
    Martinez-Lage, JM
    Marti-Climent, JM
    Serra, P
    Garcia, D
    Ramos, M
    Bescos, E
    Gomez-Isla, T
    NEUROLOGY, 2005, 64 (06) : A93 - A94
  • [40] Biomarkers of Alzheimer's disease in the CSF of patients with mild cognitive impairment
    Monge-Argiles, J. A.
    Munoz-Ruiz, C.
    Pampliega-Perez, A.
    Gomez-Lopez, M. J.
    Sanchez-Paya, J.
    Rodriguez-Borja, E.
    Ruiz-Vegara, M.
    Montoya-Gutierrez, J.
    Leiva-Santana, C.
    JOURNAL OF NEUROLOGY, 2010, 257 : S166 - S166